Co-prescribing of medications with anticholinergic properties to those using cholinesterase inhibitors for dementia

Author: Garrigan, Katherine; John, N; McGrogan, A; Jones, R; de-Vries, C

Date: 2010-08

Publisher: John Wiley & Sons, Ltd.

Type: Conference item

Link to this item using this URL: http://hdl.handle.net/2292/18890

The University of Auckland Library

Abstract

Medications with anticholinergic (AC) prop- erties have adverse effects on cognition and many guidelines recommend avoiding them in older adults. Theoretically they could negate beneļ¬ts of cholinesterase inhibitor (CI) treatment in patients dementia patients, although there is inadequate evidence to date.

Citation: ["The 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 Aug 2010 - 22 Aug 2010. Pharmacoepidemiology and Drug Safety. John Wiley & Sons, Ltd.. 19: S48-S48. Aug 2010"]

Copyright: https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm